A recent study reveals that an AI tool analyzing multiple brain scans significantly enhances the prediction of relapse risk in pediatric cancer patients with gliomas. Conducted by researchers at Mass General Brigham and affiliated institutions, the study indicates the AI's superiority over traditional approaches. Traditional methods often compel families to endure long, stressful follow-ups with MRIs, which aren't always effective in identifying high-risk patients. The study utilized temporal learning on nearly 4,000 scans from 715 patients, aiming for a more accurate assessment of recurrence risks, ultimately striving for better patient care.
AI tools trained with temporal learning can accurately predict relapse risk in pediatric glioma patients by analyzing multiple brain scans over time, outperforming traditional methods.
Benjamin Kann emphasizes the necessity of improved prediction tools in pediatric oncology, explaining that while most gliomas are curable, when relapse occurs, it can have dire consequences.
Collection
[
|
...
]